Castle Biosciences CSTL Return on invested capital

Return on invested capital at other companies

Labcorp HoldingsLH

10.3%+1.0pp

VeracyteVCYT

7.1%+4.7pp

Myriad GeneticsMYGN

-65.7%-96.6pp

Personalis, Inc.PSNL

-51.5%+9.2pp

NeoGenomicsNEO

-7.4%-2.6pp

GeneDx HoldingsWGS

-28.3%—

FAQ

What is Castle Biosciences's return on invested capital?

Castle Biosciences (CSTL) reported return on invested capital of -8.2% in Q1 2026.

How has Castle Biosciences's return on invested capital changed year-over-year?

Castle Biosciences's return on invested capital decreased by 114.7% year-over-year, from -3.8% to -8.2%.

What is the long-term trend for Castle Biosciences's return on invested capital?

Over 3 years (2022 to 2025), Castle Biosciences's return on invested capital has grown at a -33.3% compound annual growth rate (CAGR), from -38.3% to -11.4%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.